Nuclear export receptor CRM1 recognizes diverse conformations in nuclear export signals
出版年份 2017 全文链接
标题
Nuclear export receptor CRM1 recognizes diverse conformations in nuclear export signals
作者
关键词
-
出版物
eLife
Volume 6, Issue -, Pages -
出版商
eLife Sciences Organisation, Ltd.
发表日期
2017-03-10
DOI
10.7554/elife.23961
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma
- (2016) Fabrice Jardin et al. AMERICAN JOURNAL OF HEMATOLOGY
- On the acquisition and analysis of microscale thermophoresis data
- (2016) Thomas H. Scheuermann et al. ANALYTICAL BIOCHEMISTRY
- The Second-Generation Exportin-1 Inhibitor KPT-8602 Demonstrates Potent Activity against Acute Lymphoblastic Leukemia
- (2016) Thomas Vercruysse et al. CLINICAL CANCER RESEARCH
- Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma
- (2016) V. Camus et al. HAEMATOLOGICA
- Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Fludarabine and Cytarabine, in Pediatric Relapsed or Refractory Acute Leukemia
- (2016) Thomas B. Alexander et al. JOURNAL OF CLINICAL ONCOLOGY
- First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors
- (2016) Albiruni R. Abdul Razak et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma
- (2016) Mrinal M. Gounder et al. JOURNAL OF CLINICAL ONCOLOGY
- Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies
- (2016) Z A Hing et al. LEUKEMIA
- XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer
- (2016) Jimi Kim et al. NATURE
- Fully Blind Docking at the Atomic Level for Protein-Peptide Complex Structure Prediction
- (2016) Chengfei Yan et al. STRUCTURE
- Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma
- (2016) V. Camus et al. HAEMATOLOGICA
- Fully Blind Peptide-Protein Docking with pepATTRACT
- (2015) Christina E.M. Schindler et al. STRUCTURE
- A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning
- (2015) Koray Kırlı et al. eLife
- Structural determinants of nuclear export signal orientation in binding to exportin CRM1
- (2015) Ho Yee Joyce Fung et al. eLife
- Selective inhibitors of nuclear export (SINE) as novel therapeutics for prostate cancer
- (2015) Janet Mendonca et al. Oncotarget
- LocNES: a computational tool for locating classical NESs in CRM1 cargo proteins
- (2014) Darui Xu et al. BIOINFORMATICS
- Selective inhibitors of nuclear export (SINE)– a novel class of anti-cancer agents
- (2014) Kaushal Parikh et al. Journal of Hematology & Oncology
- XPO1 (CRM1) Inhibition Represses STAT3 Activation to Drive a Survivin-Dependent Oncogenic Switch in Triple-Negative Breast Cancer
- (2014) Y. Cheng et al. MOLECULAR CANCER THERAPEUTICS
- NESmapper: Accurate Prediction of Leucine-Rich Nuclear Export Signals Using Activity-Based Profiles
- (2014) Shunichi Kosugi et al. PLoS Computational Biology
- KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia
- (2013) Julia Etchin et al. BRITISH JOURNAL OF HAEMATOLOGY
- Structural diversity of calmodulin binding to its target sites
- (2013) Henning Tidow et al. FEBS Journal
- CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications
- (2013) Y-T Tai et al. LEUKEMIA
- A Unified Conformational Selection and Induced Fit Approach to Protein-Peptide Docking
- (2013) Mikael Trellet et al. PLoS One
- Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia
- (2012) R. Lapalombella et al. BLOOD
- CRM1 Blockade by Selective Inhibitors of Nuclear Export Attenuates Kidney Cancer Growth
- (2012) Hiromi Inoue et al. JOURNAL OF UROLOGY
- Identification of CRM1-dependent Nuclear Export Cargos Using Quantitative Mass Spectrometry
- (2012) Ketan Thakar et al. MOLECULAR & CELLULAR PROTEOMICS
- Sequence and structural analyses of nuclear export signals in the NESdb database
- (2012) Darui Xu et al. MOLECULAR BIOLOGY OF THE CELL
- NESdb: a database of NES-containing CRM1 cargoes
- (2012) Darui Xu et al. MOLECULAR BIOLOGY OF THE CELL
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
- (2011) Xose S. Puente et al. NATURE
- Prediction of leucine-rich nuclear export signal containing proteins with NESsential
- (2011) Szu-Chin Fu et al. NUCLEIC ACIDS RESEARCH
- Rosetta FlexPepDock ab-initio: Simultaneous Folding, Docking and Refinement of Peptides onto Their Receptors
- (2011) Barak Raveh et al. PLoS One
- NES consensus redefined by structures of PKI-type and Rev-type nuclear export signals bound to CRM1
- (2010) Thomas Güttler et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structural basis for leucine-rich nuclear export signal recognition by CRM1
- (2009) Xiuhua Dong et al. NATURE
- Crystal Structure of the Nuclear Export Receptor CRM1 in Complex with Snurportin1 and RanGTP
- (2009) T. Monecke et al. SCIENCE
- A Novel Main Chain Motif in Proteins Bridged by Cationic Groups: The Niche
- (2008) Gilleain M. Torrance et al. JOURNAL OF MOLECULAR BIOLOGY
- Nuclear Export Signal Consensus Sequences Defined Using a Localization-Based Yeast Selection System
- (2008) Shunichi Kosugi et al. TRAFFIC
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now